arrow
R

Rénata Ursu

Assistance Publique-Hopitaux de Paris
H指数:26
被引数:2,760

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Plasma proteomics for prognostic stratification in newly diagnosed primary central nervous system lymphoma

血浆蛋白质组学在 newly diagnosed primary central nervous system lymphoma 患者预后分层中的应用

2026-09-230
PRE
CAR T-Cell Therapy in Patients With Primary Central Nervous System Lymphoma: A LOC Network Study

原发性中枢神经系统淋巴瘤患者的CAR T细胞疗法:一项LOC网络研究

2026-05-170
OAAI
B CAR T-CELL THERAPY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS: A MULTICENTER RETROSPECTIVE STUDY FROM THE LOC NETWORK

B CAR T细胞疗法在原发性中枢神经系统淋巴瘤中的应用:LOC网络的多中心回顾性研究

2025-10-010
OA
Unveiling the Clinical and Imaging Signatures of Intravascular Lymphoma of the Central Nervous System: A Multicentric Cohort Study
2024-11-280
PRE
CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network

CAR T细胞疗法在复发性原发性中枢神经系统淋巴瘤中诱导高缓解率: LOC网络的现实结果

2024-04-087
OAAI
UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM
2023-09-080
OA
[18F]FDG PET-MRI provides survival biomarkers in primary central nervous system lymphoma in the elderly: an ancillary study from the BLOCAGE trial of the LOC network
2023-07-186
PRE
Molecular and clinical diversity in primary central nervous system lymphoma
2023-02-0132
OA
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

实体癌患者冠状病毒疾病2019 (新型冠状病毒肺炎) 严重程度和死亡率的危险因素以及该疾病对抗癌治疗的影响: 法国全国队列研究 (GCO-002 CACOVID-19)

2020-12-01121
OAAI